Daclizumab and ascites Patient Reports February 12, 2012

Daclizumab Side Effects Report #4792910-0
Daclizumab side effect was reported by a Physician from GERMANY on Aug 24, 2005. Female patient, 59 years of age, was treated with Daclizumab. After drug was administered, patient experienced the following side effects: ascites, aspergillosis, candidiasis, haematoma infection, post procedural complication, sepsis , wound dehiscence. Daclizumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, TACROLIMUS, METHYLPREDNISOLONE, PREDNISONE. Patient was hospitalized. Patient died on 09/28/2005.

Daclizumab Side Effects Report #5320377-2
Daclizumab side effect was reported by a Physician from UNITED KINGDOM on May 02, 2007. Female patient, 44 years of age, was treated with Daclizumab. After drug was administered, patient experienced the following side effects: abdominal sepsis, ascites, atrial fibrillation , cellulitis , enterococcal infection, escherichia infection, gastrointestinal haemorrhage, haematoma, haemoglobin decreased. Daclizumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL. Patient was hospitalized and became disabled. Patient died on 06/14/2005.

Daclizumab Side Effects Report #4653623-9
Daclizumab side effect was reported by a Physician from on Apr 27, 2005. Female patient, 44 years of age, was treated with Daclizumab. After drug was administered, patient experienced the following side effects: ascites, blood albumin decreased, culture positive, neutrophil count increased, oedema peripheral, pleural effusion, renal impairment, skin laceration, white blood cell count increased. Daclizumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, TACROLIMUS. Patient was hospitalized. Patient recovered.

Daclizumab Side Effects Report #4657902-0
Daclizumab side effect was reported by a Physician from on Apr 27, 2005. Female patient, 44 years of age, was treated with Daclizumab. After drug was administered, patient experienced the following side effects: ascites, blood albumin decreased, escherichia infection, laceration, neutrophil count decreased, oedema peripheral, pleural effusion, renal impairment, white blood cell count increased. Daclizumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, TACROLIMUS. Patient was hospitalized. Patient recovered.


Daclizumab Side Effects Report #4661735-9
Daclizumab side effect was reported by a Physician from on Apr 27, 2005. Female patient, 44 years of age, was treated with Daclizumab. After drug was administered, patient experienced the following side effects: ascites, blood albumin decreased, escherichia infection, gastrointestinal haemorrhage, laceration, oedema peripheral, pleural effusion, renal impairment, white blood cell count increased. Daclizumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL. Patient was hospitalized. Patient recovered.

Daclizumab Side Effects Report #4662520-4
Daclizumab side effect was reported by a Physician from on Apr 27, 2005. Female patient, 44 years of age, was treated with Daclizumab. After drug was administered, patient experienced the following side effects: ascites, blood albumin decreased, culture positive, escherichia infection, gastrointestinal haemorrhage, laceration, oedema peripheral, pleural effusion, renal impairment. Daclizumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL. Patient was hospitalized. Patient recovered.

Daclizumab Side Effects Report #4666052-9
Daclizumab side effect was reported by a Physician from on Apr 27, 2005. Female patient, 44 years of age, was treated with Daclizumab. After drug was administered, patient experienced the following side effects: ascites, escherichia infection, gastrointestinal haemorrhage, laceration, oedema peripheral, pleural effusion, renal impairment, small intestinal haemorrhage, white blood cell count increased. Daclizumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL. Patient was hospitalized. Patient recovered.

Daclizumab Side Effects Report #4766453-4
Daclizumab side effect was reported by a Physician from UNITED KINGDOM on Apr 27, 2005. Female patient, 44 years of age, was treated with Daclizumab. After drug was administered, patient experienced the following side effects: abdominal sepsis, ascites, atrial fibrillation , blood albumin decreased, blood culture positive, cellulitis , complications of transplanted liver, diarrhoea, enterococcal infection. Daclizumab dosage: unknown. During the same period patient was treated with MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL. Patient was hospitalized and became disabled. Patient died on 06/14/2005.

Daclizumab Side Effects Report #4564217-8
Daclizumab side effect was reported by a Physician from on Jan 18, 2005. Female patient, child 2 years of age, weighting 35.27 lb, was treated with Daclizumab. After drug was administered, patient experienced the following side effects: ascites, bacterial infection , catheter related infection, cytomegalovirus infection , dehydration, enterococcal bacteraemia, fluid overload, lymphocele, pneumonia . Daclizumab dosage: unknown. During the same period patient was treated with TACROLIMUS, PREDNISONE, PREDNISOLONE, AZATHIOPRINE, PRILOSEC, ASPIRIN, LOMOTIL. Patient was hospitalized. Patient recovered.


Daclizumab Side Effects Report #4588224-4
Daclizumab side effect was reported by a Physician from on Jan 18, 2005. Female patient, child 2 years of age, weighting 36.16 lb, was treated with Daclizumab. After drug was administered, patient experienced the following side effects: ascites, bacterial infection , catheter related infection, cytomegalovirus infection , dehydration, enterococcal infection, hepatic enzyme increased, lobar pneumonia, lymphocele. Daclizumab dosage: unknown. During the same period patient was treated with TACROLIMUS, PREDNISONE, AZATHIOPRINE, PRILOSEC, ASPIRIN, LOMOTIL. Patient was hospitalized. Patient recovered.

Daclizumab Side Effects Report #4597500-0
Daclizumab side effect was reported by a Physician from on Jan 18, 2005. Female patient, child 2 years of age, weighting 36.16 lb, was treated with Daclizumab. After drug was administered, patient experienced the following side effects: ascites, bacterial infection , catheter related infection, cytomegalovirus infection , dehydration, enterococcal infection, fluid overload, liver function test abnormal, lymphocele. Daclizumab dosage: unknown. During the same period patient was treated with TACROLIMUS, PREDNISONE, PREDNISOLONE, AZATHIOPRINE, PRILOSEC, ASPIRIN, LOMOTIL. Patient was hospitalized. Patient recovered.

Daclizumab Side Effects Report #4704007-6
Daclizumab side effect was reported by a Physician from on Jan 18, 2005. Female patient, weighting 36.16 lb, was treated with Daclizumab. After drug was administered, patient experienced the following side effects: ascites, bacterial infection , catheter related infection, clostridium difficile toxin test positive, cytomegalovirus infection , dehydration, diarrhoea, enterococcal infection, fluid overload. Daclizumab dosage: unknown. During the same period patient was treated with TACROLIMUS, PREDNISONE, PREDNISOLONE, AZATHIOPRINE, SIROLIMUS. Patient was hospitalized. Patient recovered.